Your browser does not support javascript:   Search for gard hereSearch for news-and-events here.

Diseases

Genetic and Rare Diseases Information Center (GARD)

Dense deposit disease


Other Names for this Disease
  • Glomerulonephritis membranoproliferative type 2
  • Mesangiocapillary glomerulonephritis type 2
  • MPGN 2
  • Membranoproliferative glomerulonephritis type II
  • DDD
See Disclaimer regarding information on this site. Some links on this page may take you to organizations outside of the National Institutes of Health.

Research

Clinical Trials & Research for this Disease

  • ClinicalTrials.gov lists trials that are studying or have studied Dense deposit disease. Click on the link to go to ClinicalTrials.gov to read descriptions of these studies.
  • The North American Pediatric Renal Trials and Collaborative Studies (NAPRTCS) is a research effort organized in 1987 that hopes to register and follow greater than 80% of the children receiving renal allografts in North America, and study the clinical course and natural history of patients with renal dysfunction and to continue following these patients as they move among the end-stage renal disease (ESRD) therapeutic modalities, thus allowing the NAPRTCS to become a complete ESRD patient data system.
Other Names for this Disease
  • Glomerulonephritis membranoproliferative type 2
  • Mesangiocapillary glomerulonephritis type 2
  • MPGN 2
  • Membranoproliferative glomerulonephritis type II
  • DDD
See Disclaimer regarding information on this site. Some links on this page may take you to organizations outside of the National Institutes of Health.